[
    [
        {
            "time": "2020-06-15",
            "original_text": "The Dow Slipped 109 Points Because Reopened Economies Aren’t Business as Usual",
            "features": {
                "keywords": [
                    "Dow",
                    "Slipped",
                    "Reopened Economies"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "The Dow Slipped 109 Points Because Reopened Economies Aren’t Business as Usual",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "AbbVie Stock Is ‘Unsustainably Cheap’ After Allergan Acquisition",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Stock",
                    "Unsustainably Cheap",
                    "Allergan Acquisition"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Stock Is ‘Unsustainably Cheap’ After Allergan Acquisition",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "AbbVie Garners Two Favorable Analyst Reviews After Allergan Merger",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Favorable Analyst Reviews",
                    "Allergan Merger"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Garners Two Favorable Analyst Reviews After Allergan Merger",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Valuation",
                    "Dividend Yield",
                    "Confidence in Guidance"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Form 8.3 - AbbVie Inc.",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "AbbVie Inc."
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "regulatory"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Form 8.3 - AbbVie Inc.",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "AbbVie Wraps Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Allergan Buyout",
                    "Stock Buy"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Wraps Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Form 8.3 - ABBVIE INC",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "ABBVIE INC"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "regulatory"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Form 8.3 - ABBVIE INC",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        }
    ]
]